PTEN loss is associated with worse outcome in HER2-Amplified breast cancer patients but is not associated with trastuzumab resistance

1. Stern, H.M.
2. Gardner, H.
3. Burzykowski, T.
4. Elatre, W.
5. O'Brien, C.
6. Lackner, M.R.
7. Pestano, G.A.
8. Santiago, A.
9. Villalobos, I.
10. Eiermann, W.
11. Pienkowski, T.
12. Martin, M.
13. Robert, N.
14. Crown, J.
15. Nuciforo, P.
16. Bee, V.
17. Mackey, J.
18. Slamon, D.J.
19. Press, M.F.